Advertisements
Daka et al
|
Greener Journal of Medical Sciences Vol. 11(2), pp. 159-171, 2021 ISSN: 2276-7797 Copyright ©2021, the copyright of this article is retained by the author(s) |
|
The Prevalence of Dyslipidemia in the Niger Delta Region of Southern Nigeria
Daka, I.R.1*; Amaewhule, M.N.2; Wekhe C.3
1Department of Pharmacology, Rivers State University, Port Harcourt, Nigeria.
2Department of Internal Medicine, Rivers State University, Port Harcourt, Nigeria.
3Department of Radiology, Rivers State University, Port Harcourt, Nigeria
|
ARTICLE INFO |
ABSTRACT |
|
Article No.: 102121108 Type: Research |
Background: Dyslipidaemia is a general term used to describe high levels of LDL-C, TGs or low levels of HDL. They are major to atherosclerosis and its related conditions such as coronary heart disease, ischemic cerebrovascular disease and peripheral vascular disease. Data are scanty on the prevalence and pattern of dyslipidemia in Nigeria. However, some studies on the subject are now becoming available. . The objective of this study is to assess the prevalence of dyslipidemia in a sub-urban community in Niger Delta region of Southern Nigeria Method: A cross-sectional study carried out among 107 participants ( 80 females and 27 males) aged between 23 and 80 years. They were first administered a structured questionnaire to obtain their socio-demographic data and lifestyle characteristics after which anthropometric assessment was performed. Thereafter, their blood pressure was taken and blood samples collected for blood sugar and lipid analysis. Results: The prevalence of the various components of metabolic syndrome was also accessed and 18 (16.8%) had reduced high density lipoprotein cholesterol, 6 (5.6%) had raised triglyceride.It was found that 70 (65.4%) of the respondents had high blood pressure, 54 (50.5%) had raised blood sugar, 48(44.9%) had abdominal obesity, 31(29.0%) had central obesity. Dyslipidemia was highly prevalent in this geopolitical zone of Nigeria with the consistent pattern being low HDL-Cholesterol and high LDL-C. Conclusion: Dyslipidemia is highly prevalent in Southern Nigeria and health education to increase awareness of the need for and to actually screen for dyslipidemia will facilitate early detection and treatment. |
|
Accepted: 22/10/2021 Published: 04/11/2021 |
|
|
*Corresponding Author Daka, I.R. E-mail: iyaeneomidaka@ gmail.com |
|
|
Keywords: Dyslipidemia; adult population; prevalence |
|
|
|
|
Return to Content View [Full Article - PDF] |
REFERENCES
|
Cziraky MJ. Management of dyslipidaemia in
patients with metabolic syndrome. J Am Pharm Assoc (Wash) 2004;44:478-88. |
|
|
Enas EA. Clinical implications: Dyslipidaemia in
the Asian Indian population. Information Available from http://www.southasianheartcentre.org/dois/AAPLmonograph.pdf [Last Accessed on 2009 Jan 6]. |
|
|
Dyslipidaemia: Lipid disorders: Merck manual
professional; file: Available from http://www.///H:/dyslipidaemia.htm 1-7 [Lat Accessed on 2009 May 14]. |
|
|
Executive summary of the third report of the
National Cholesterol Education Program (NCEP) Expert Panel on Detection,
Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III). JAMA 2001;285:2486. |
|
|
European Atherosclerosis Society. International
Task Force for prevention of coronary heart disease. Scientific background
and new clinical guidelines. Nutr Metab Cardiovascular Dis
1992;2:113-56. |
|
|
Report of WHO Scientific Group. Cardiovascular
disease risk factors: New areas for research. WHO Technical Report Series No
841. Geneva: WHO; 1994. |
|
|
World Health Organization (WHO). Familial
hypercholesterolaemia (FH): Report of a WHO consultation:
WHO/HGN/CONS/98.7. |
|
|
Tekes-Manova D, Israeli E, Shochat T, Swartzon M,
Gordon S, Heruti R, et al. The Prevalence of Reversible
Cardiovascular Risk Factors in Israelis aged 25-55 years. IMAJ
2006;8:527-31. |
|
|
Cullen P, Schulte H, Assmann G. The Munster Heart
Study (PROCAM). Total mortality in middle aged men is increased at low total
cholesterol and LDL cholesterol concentrations in smokers but not in
non-smokers. Circulation 1997;96:2128-36. |
|
|
WHO. Quantifying selected major risks to health.
In: The WHO Report 2002- Reducing risks, promoting healthy life. Chap 4:
Geneva: WHO; 2002. p. 47-97. |
|
|
Coronary heart disease mortality trends among
whites and blacks-Appalachia and United States 1980-1993. MMWR Morb Mortal
Wkly Rep 1998;47:1005-12. |
|
|
Stamler J, Daviglus ML, Garside DB. Relationship
of baseline serum cholesterol levels in 3 large cohorts of younger men to
long term coronary, cardiovascular and all cause mortality and to longevity.
JAMA 2000;284:311-21. |
|
|
Scientific Steering Committee on behalf of the
Simon Broome Register Group. Mortality in treated heterozygous familial
hypercholesterolaemia: Implications for clinical management. Atherosclerosis
1999;142:105-15. |
|
|
Verschuren WMM, Blockstra A, Boerma GJM, Kromhout
D. Trends in serum total cholesterol level in 110,000 young adults in the
Netherlands-1974 to 1986. Am J Epidemiol 1991;134:290-302. |
|
|
Law MR, Wald NJ, Thompson SG. By how much and how
quickly does reduction in serum cholesterol lower risk of ischaemic heart
disease?. Br Med J 1994;308:367-72. |
|
|
Gould AL, Rossouw JE, Santanello NC, Heyse JF,
Furberg CD. Cholesterol reduction yields clinical benefit: Impact of statin
trials. Circulation 1998;97:946-54. |
|
|
Genest JJ, Martin-Munley SS, McNamara JR.
Familial lipoprotein disorders in patients with premature coronary artery
disease. Circulation 1992;85:2025-31. |
|
|
Onyemelukwe GC, Stafford WL. Serum lipids in
Nigerians: The effect of diabetes mellitus. Trop Geogr Med
1981;33:323-8. |
|
|
Kesteloot H, Oviasu VO, Obasohan AO, Olomu A,
Cobbaert C, Lissens W. Serum lipid and apoprotein levels in a Nigerian
population sample. Atherosclerosis 1989;78:33-8. |
|
|
Odenigbo CU, Oguejiofor OC, Odenigbo UM, Ibeh CC,
Ajaero CN, Odike MA. Prevalence of dyslipidaemia in apparently healthy
professionals in Asaba, South South Nigeria. Nig j Clin Pract
2008;11:330-5. |
|
|
Agboola-Abu CF, Onabolu A. Plasma lipid levels in
patients attending Igbinedion hospital and medical research centre, Okada,
Edo State, Nigeria. Nig Med J 2000;38:1-5. |
|
|
Osuji CU, Nzerem BA, Meludu S, Dioka CE, Nwobodo
E, Amilo GI. The prevalence of overweight/obesity and dyslipidaemia amongst a
group of women attending "August" meeting. Niger Med J
2010;51:155-9. |
|
|
Sani MU, Wahab KW, Yusuf BO, Gbadamosi M, Johnson
OU, Gbadamosi A. Modifiable cardiovascular risk factors among apparently
healthy adult Nigerian population-a cross sectional study. BMC Research notes
2010;3:11. |
|
|
Odenigbo CU, Odenigbo UM, Oguejiofor OC, Okonkwo
UC, Oguanobi NI. Prevalence of dyslipidaemia in elderly subjects in Asaba,
South South Nigeria. J Indian Acad Geriatr 2010;6:160-4. |
|
|
Ogbera AO, Fasanmade OA, Chinenye S, Akinlade A.
Characterization of lipid parameters in diabetes mellitus-a Nigerian report.
Int Arch Med 2009;2:19.
|
|
|
Okafor CI, Fasanmade OA, Oke DA. Pattern of
dyslipidaemia among Nigerians with type 2 diabetes mellitus. Nig J Clin Pract
2008;11:25-31.
|
|
|
Idogun ES, Unuigbe EI, Ogunro PS, Akinola OT,
Famodu AA. Assessment of serum lipids in Nigerians with type 2 diabetes
mellitus complications. Pak J Med Sci 2007;23:708-12. |
|
|
Agaba IE, Anteyi EA, Puepet FH, Omodu PA, Idoko
JA. The clinical pattern of diabetic nephropathy in type 2 diabetes mellitus
in North Central Nigeria. Journal of Med Tropics 2002;4:10. |
|
|
Akintunde AA, Ayodele EO, Akinwusi OP, Opadijo
GO. Dyslipidaemia among newly diagnosed hypertensives: Pattern and clinical
correlates. J Natl Med Assoc May 2010;102:403-7.
|
|
|
Ojji DB, Ajayi SO, Mamven MH, Antherton J.
Prevalence of dyslipidaemia in normoglycemic subjects with newly diagnosed
high blood pressure in Abuja Nigeria. J Clin Lipid 2009;3:51-6. |
|
|
Isezuo SA, Badung SL, Omotosho AB. Comparative
analysis of lipid profiles among patients with type 2 diabetes mellitus,
hypertension and concurrent type 2 diabetes, and hypertension. A view of
metabolic syndrome. J Natl Med Assoc 2003;95:328-34. |
|
|
American Heart Association. Cholesterol
Statistics. Available from: http://www.americanheart.org/presenter.jhtml?identifier=536. [Last Assessed on 2006 Nov 20]. |
|
|
Goff DC, Bertoni AG, Kramer H, Bonds D,
Blumenthal RS, Tsai MY, et al. Dyslipidaemia prevalence, treatment
and control in the Multi-Ethnic Study of Atherosclerosis: Gender, Ethnicity
and Coronary Artery Calcium. Circulation 2006;113:647-56. |
|
|
Buch-Johnsen K. The Metabolic Syndrome in a
global perspective. The public Health impact. Dan Med Bull
2007;54:157-9. |
|
|
Akbar DH. Hyperlipidaemia in Diabetic Patients in
Saudi Arabia. Diabetes Int 2001;1:17-8. |
|
|
Vezi ZB, Naidoo DP. Dyslipidaemia among Black
patients with Type 2 Diabetes. Cardiovasc J S Afr 2005;16:194-8.
|
|
|
37 |
Lepira FB, M′Buyamba-Kabangu JR, Kayemba KP, Nseka MN. Correlates of
serum lipids and lipoproteins in Congolese patients with arterial
hypertension. Cardiovasc J S Afr 2005;16:249-55. |
|
Cite this Article: Daka, IR; Amaewhule, MN; Wekhe C (2021). The Prevalence of Dyslipidemia in the Niger Delta Region of Southern Nigeria. Greener Journal of Medical Sciences, 11(2): 159-171.
|
Call for Papers
Call for Scholarly Articles
Authors from around the world are invited to send scholary articles that suits the scope of this journal. The journal is currently open to submissions and will process and publish articles monthly in two yearly issues.
The journal is centered on quality and goes about its processes in a very timely fashion. Seasoned editors/reviewers will be consulted to review each article(s), profer quality evaluations and polish the articles with expertise before publication.
Simply send your article(s) as an e-mail attachment to manuscripts@acad.gjournals.org or manuscripts.igj@gmail.com.
Advertisements
